Azide-PEG12-Tos

CAS No. 1821464-56-5

Azide-PEG12-Tos ( —— )

Catalog No. M26890 CAS No. 1821464-56-5

Azide-PEG12-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 75 Get Quote
10MG 107 Get Quote
25MG 176 Get Quote
50MG 260 Get Quote
100MG 385 Get Quote
200MG 570 Get Quote
500MG 888 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Azide-PEG12-Tos
  • Note
    Research use only, not for human use.
  • Brief Description
    Azide-PEG12-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • Description
    Azide-PEG12-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    BRD4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1821464-56-5
  • Formula Weight
    725.9
  • Molecular Formula
    C31H55N3O14S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1ccc(cc1)S(=O)(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yao, Zhiyi. BRD4 small molecule inhibitor with antitumor activity and its preparation. CN107721975A
molnova catalog
related products
  • alpha-Dihydroartemis...

    Dihydroartemisinin is widely used as an intermediate in the preparation of other artemisinin-derived antimalarial drugs, is recommended as the first-line anti-malarial drug with low toxicity. Dihydroartemisinin possesses promising anticancer activities and induce cancer cell death through apoptotic pathways.

  • Bromo-PEG1-C2-azide

    Bromo-PEG1-C2-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • Stiripentol

    Stiripentol (STP) is an anticonvulsant agent, which can inhibit N-demethylation of CLB to NCLB mediated by CYP3A4 (noncompetitively) and CYP2C19 (competitively) with Ki of 1.59/0.516 μM and IC50 of 1.58/3.29 μM, respectively.